Arcturus Therapeutics ARCT and partner CSL Seqirus, a renowned vaccine company, together reported encouraging results from a ...

CSL and Arcturus Therapeutics report that their sa-mRNA COVID-19 vaccine, ARCT-154, delivered superior immunogenicity ...

A head-to-head study has revealed that CSL and Arcturus Therapeutic’s self-amplifying mRNA vaccine can maintain a stronger ...

Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...

It’s been over four years since the beginning of the COVID-19 pandemic. And since then, the virus has changed substantially.

According to The People’s Vaccine Alliance, Comirnaty costs an estimated $1.18 per dose to produce. For over two years now, the US government has been running its public vaccination campaign ...

BioNTech is the Marketing Authorization Holder for COMIRNATY ® and its adapted vaccines (COMIRNATY ® (COVID-19 Vaccine, mRNA); COMIRNATY ® Original/Omicron BA.1; COMIRNATY ® Original/Omicron BA.

2-adapted monovalent Covid-19 vaccine (Comirnaty KP.2) for active immunization to prevent Covid-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The European Commission will review ...

During the pandemic, Pfizer gave the world the first and most widely used vaccine, Comirnaty, and the oral antiviral pill, Paxlovid. Though in 2021/2022, no company was as strongly placed as ...